Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ONCOLYTICS BIOTECH INC.”

63 pharma patents match "ONCOLYTICS BIOTECH INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 63
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 63 pharmaceutical patents matching "ONCOLYTICS BIOTECH INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

63 results for “ONCOLYTICS BIOTECH INC.” · 30,257 patents in full index Clear search

  1. US 11246930

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

  2. US 10596260

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  3. US 10167452

    Viral purification methods

    ONCOLYTICS BIOTECH INC. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  4. US 10039827

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  5. US 9610309

    Liquid viral formulations

    ONCOLYTICS BIOTECH INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  6. US 9610352

    Lyophilized viral formulations

    ONCOLYTICS BIOTECH INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  7. US 9365823

    Virus clearance of neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  8. US 9045728

    Liquid viral formulations

    ONCOLYTICS BIOTECH INC. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  9. US 9044498

    Lyophilized viral formulations

    ONCOLYTICS BIOTECH INC. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  10. US 8709443

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  11. US 8691241

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  12. US 8685734

    Viral purification methods

    ONCOLYTICS BIOTECH INC. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  13. US 8658158

    Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

    ONCOLYTICS BIOTECH INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  14. US 8512712

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  15. US 8491886

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  16. US 8491884

    Virus clearance of neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  17. US 8470312

    Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

    ONCOLYTICS BIOTECH INC. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  18. US 8147845

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted

  19. US 8080241

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted

  20. US 8071087

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  21. US 8066985

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  22. US 7964187

    Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

    ONCOLYTICS BIOTECH INC. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  23. US 7964186

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  24. US 7901921

    Viral purification methods

    ONCOLYTICS BIOTECH INC. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.